CFB - age-related macular degeneration

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Age-related Macular Degeneration (AMD)
  • Conditions > Vision impairment / blindness > Age-related Macular Degeneration (AMD)

This product is also part of the following panels:

  • WES hemostatic/thrombotic disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES primary immunodeficiencies (100.0% *)
  • WES renal disorders (100.0% *)
  • WES renal disorders (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 138470
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725

Gene

C3 - age-related macular degeneration

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

C3 - age-related macular degeneration



€ 725

C3 - age-related macular degeneration

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Age-related Macular Degeneration (AMD)
  • Conditions > Vision impairment / blindness > Age-related Macular Degeneration (AMD)

This product is also part of the following panels:

  • WES comprehensive preconception carrier test ¹
  • WES hemostatic/thrombotic disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES primary immunodeficiencies (100.0% *)
  • WES renal disorders (100.0% *)
  • WES renal disorders (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 120700
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFB - age-related macular degeneration

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFB - age-related macular degeneration



€ 725
Gene

CFH - age-related macular degeneration

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFH - age-related macular degeneration



€ 725

CFH - age-related macular degeneration

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Age-related Macular Degeneration (AMD)
  • Conditions > Vision impairment / blindness > Age-related Macular Degeneration (AMD)

This product is also part of the following panels:

  • WES comprehensive preconception carrier test ¹
  • WES hemostatic/thrombotic disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES primary immunodeficiencies (100.0% *)
  • WES renal disorders (100.0% *)
  • WES renal disorders (100.0% *)
  • WES vision disorders (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 134370
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725
Gene

CFI - age-related macular degeneration

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 725

CFI - age-related macular degeneration



€ 725

CFI - age-related macular degeneration

This test is available for the following conditions:

  • Conditions > Complement-mediated diseases > Age-related Macular Degeneration (AMD)
  • Conditions > Vision impairment / blindness > Age-related Macular Degeneration (AMD)

This product is also part of the following panels:

  • WES comprehensive preconception carrier test ¹
  • WES hemostatic/thrombotic disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES Mendelian inherited disorders (100.0% *)
  • WES primary immunodeficiencies (100.0% *)
  • WES renal disorders (100.0% *)
  • WES renal disorders (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 217030
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 725